Found: 16
Select item for more details and to access through your institution.
ONCOLYTIC ACTIVITY OF HUMAN ORTHOPNEUMOVIRUS IN CANCER CELL LINES.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 113, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.18084
- By:
- Publication type:
- Article
CHEMORESISTANCE RELATED TO HYPOXIA ADAPTATION IN MESOTHELIOMA CELLS FROM TUMOR SPHEROIDS.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 121, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.18045
- By:
- Publication type:
- Article
TRANSCRIPTIONAL ANALYSIS OF ZINC-DEPENDENT HISTONE DEACETYLASES IN SEVERAL HUMAN CANCER CELLS.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 126, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17983
- By:
- Publication type:
- Article
CLINICAL CASE OF NON-TYPICAL METASTASIS OF NEUROENDOCRINE LUNG CARCINOMA TO THE VASCULAR MEMBRANE OF THE EYE.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 169, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17969
- By:
- Publication type:
- Article
PRIMARY CUTANEOUS ADENOID CYSTIC CARCINOMA IN THE TRUNK: CASE REPORT AND LITERATURE REVIEW.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 174, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.18006
- By:
- Publication type:
- Article
EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICIN.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 107, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17886
- By:
- Publication type:
- Article
SERUM ANTIBODIES AGAINST GROEL AS AN ADDITIONAL RISK BIOMARKER OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 163, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17827
- By:
- Publication type:
- Article
SYMBIOSIS OF MEDICAL TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: NEW OPPORTUNITIES IN ONCOLOGY.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 90, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17951
- By:
- Publication type:
- Article
THE CHANGES OF NO LEVEL AND RNASE ACTIVITY IN TUMOR TISSUE ACCOMPANYING THE PROGRESSION OF PROSTATE CANCER.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 159, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17785
- By:
- Publication type:
- Article
ANTIMETASTATIC EFFECT OF B. SUBTILIS IMV B-7724 LECTIN OBSERVED IN LEWIS LUNG CARCINOMA MODEL.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 155, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17914
- By:
- Publication type:
- Article
POLYAMINES AS NEW POTENTIAL BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND ESTIMATION OF ITS AGGRESSIVENESS.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 148, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17758
- By:
- Publication type:
- Article
SIGNIFICANCE OF ADC MEASUREMENTS AS RADIOLOGICAL MRI MARKER IN DETECTION OF METASTATIC LYMPH NODE INVOLVEMENT IN PATIENTS WITH PROSTATE CANCER.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 142, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17810
- By:
- Publication type:
- Article
EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLS.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 137, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.18025
- By:
- Publication type:
- Article
EXPRESSION OF miRNA AS PROGNOSTIC MARKERS OF RENAL CELL CARCINOMA COURSE.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 132, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17883
- By:
- Publication type:
- Article
HUMAN MICROBIOTA AND BREAST CANCER.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 95, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17855
- By:
- Publication type:
- Article
OECI 2022 ONCOLOGY DAYS AND GENERAL ASSEMBLY: The OECI 2022 Oncology Days and the OECI General Assembly were held in Valencia (Spain) on June 15-17.
- Published in:
- Experimental Oncology, 2022, v. 44, n. 2, p. 93, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-2.17945
- By:
- Publication type:
- Article